You have free access to this content

American Journal of Transplantation

Cover image for Vol. 12 Issue 10

October 2012

Volume 12, Issue 10

Pages 2565–2863

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 2565–2566)

      SUE PONDROM

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04296.x

      In a climate of mainstream media stories touting the latest discoveries in regenerative medicine and claims from what are sometimes referred to as “stem cell clinics,” this month “The AJT Report” takes a look at how regenerative medicine fits into the field of transplantation, and how we might balance the competing forces of science and fiction.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      LITERATURE Watch: Implications for transplantation (page 2567)

      HETH R. TURNQUIST, JONATHAN S. BROMBERG and Jonathan S. Bromberg

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04297.x

      • image

      Findings from several new studies provide insights into innate cell and IL-33 immunobiology, and identify several new targets of therapeutic modalities for antibody-mediated rejection.

  3. Editorials

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      The Graying of Organ Transplantation (pages 2569–2570)

      D. R. Goldstein

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04246.x

      The author discusses some of the key biological issues in how aging impacts organ transplantation. See meeting report by Abecassis et al on page 2608.

    2. You have free access to this content
      A Novel Definition of Cardiac Allograft Vasculopathy (pages 2571–2572)

      H. J. Eisen

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04240.x

      The author reviews the article by Arora and colleagues (page 2700) and puts into context the observations made regarding the use of everolimus in patients several years out from transplant with established cardiac allograft vasculopathy, as well as the utility of the novel imaging technique, virtual histology, used in the study.

    3. You have free access to this content
      Is the Time Ripe for Genomic Diagnosis and Prediction of Rejection? (pages 2573–2574)

      J. S. Bromberg and D. Iklé

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04250.x

      Citing the novel evidence and analyses of Li et al (page 2710) regarding genomic tools for the diagnosis of renal allograft rejection, the authors discuss the significant challenges related to the validation of these findings and their translation to predictive indicators.

  4. Comprehensive Review

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      Role of the PD-1 Pathway in the Immune Response (pages 2575–2587)

      L. V. Riella, A. M. Paterson, A. H. Sharpe and A. Chandraker

      Article first published online: 17 AUG 2012 | DOI: 10.1111/j.1600-6143.2012.04224.x

      • image
      • image
      • image

      The authors review the current knowledge of the critical and diverse immunoregulatory functions of the PD-1 pathway and its therapeutic potential in transplantation.

  5. Minireviews

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      The Role of Costimulatory Molecules in Directing the Functional Differentiation of Alloreactive T Helper Cells (pages 2588–2600)

      C. N. Magee, O. Boenisch and N. Najafian

      Article first published online: 3 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04180.x

      • image

      This review discusses the influence of co-stimulatory molecules on T helper cell differentiation in the alloimmune response, with particular emphasis on the therapeutic implications of co-stimulatory blockade.

    2. You have free access to this content
      Calcineurin Inhibitor Sparing With Mycophenolate Mofetil in Liver Transplantion: A Systematic Review of Randomized Controlled Trials (pages 2601–2607)

      A. D. Goralczyk, N. Bari, W. Abu-Ajaj, T. Lorf, G. Ramadori, T. Friede and A. Obed

      Article first published online: 19 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04157.x

      • image
      • image

      In this systematic review and meta-analysis the authors summarize the evidence from randomized controlled trials concerning the use of mycophenolate mofetil in liver transplant recipients with the aim to spare calcineurin inhibitors and thereby prevent impairment of kidney function.

  6. Meeting Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      Solid-Organ Transplantation in Older Adults: Current Status and Future Research (pages 2608–2622)

      M. Abecassis, N. D. Bridges, C. J. Clancy, M. A. Dew, B. Eldadah, M. J. Englesbe, M. F. Flessner, J. C. Frank, J. Friedewald, J. Gill, C. Gries, J. B. Halter, E. L. Hartmann, W. R. Hazzard, F. M. Horne, J. Hosenpud, P. Jacobson, B. L. Kasiske, J. Lake, R. Loomba, P. N. Malani, T. M. Moore, A. Murray, M.-H. Nguyen, N. R. Powe, P. P. Reese, H. Reynolds, M. D. Samaniego, K. E. Schmader, D. L. Segev, A. S. Shah, L. G. Singer, J. A. Sosa, Z. A. Stewart, J. C. Tan, W. W. Williams, D. W. Zaas and K. P. High

      Article first published online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04245.x

      • image
      • image
      • image
      • image

      This paper summarizes the proceedings of a recent trans-disciplinary workshop on transplantation in the elderly, presenting the current status and issues of transplantation in older adults and outlining important areas for research. See editorial by Goldstein on page 2569.

  7. Personal Viewpoint

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      Transplant Organizational Structures: Viewpoints From Established Centers (pages 2623–2629)

      M. Abouljoud, G. Klintmalm and S. Whitehouse

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04189.x

      • image

      This report of an opinion survey of 20 U.S. transplant programs outlines prevailing themes and opinions regarding the optimal structure of modern transplant practice environments.

  8. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. Basic Science

      You have free access to this content
      Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody (pages 2630–2640)

      N. Poirier, C. Mary, N. Dilek, J. Hervouet, D. Minault, G. Blancho and B. Vanhove

      Article first published online: 3 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04164.x

      • image
      • image
      • image
      • image
      • image
      • image

      FR104 is a novel monovalent Fab′ antagonist anti-CD28 antibody that shows complete absence of immunotoxicity and demonstrates efficacy to fight acute graft-versus-host disease in a humanized mouse model.

    2. You have free access to this content
      Patterns of De Novo Allo B Cells and Antibody Formation in Chronic Cardiac Allograft Rejection After Alemtuzumab Treatment (pages 2641–2651)

      J. Kwun, B. C. Oh, A. C. Gibby, R. Ruhil, V. T. Lu, D. W. Kim, E. K. Page, O. P. Bulut, M. Q. Song, A. B. Farris, A. D. Kirk, S. J. Knechtle and N. N. Iwakoshi

      Article first published online: 3 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04181.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      The authors demonstrate that an endogenous de novo allo B cell response after isolated T cell depletion in a CD52 transgenic mouse cardiac allograft model leads to de novo alloantibody production and antibody-mediated chronic rejection.

    3. You have free access to this content
      Analysis of Human Biologics With a Mouse Skin Transplant Model in Humanized Mice (pages 2652–2662)

      F. Waldron-Lynch, S. Deng, P. Preston-Hurlburt, O. Henegariu and K. C. Herold

      Article first published online: 17 AUG 2012 | DOI: 10.1111/j.1600-6143.2012.04178.x

      • image
      • image
      • image
      • image
      • image
      • image

      These studies involve the analysis of a xenogeneic skin graft in CD34+ stem cell-reconstituted humanized mice and show how this model can be used to investigate the ability of human immune therapies to enhance or suppress functional human immune responses.

    4. You have free access to this content
      T Regulatory Cells Play a Significant Role in Modulating MHC Class I Antibody-Induced Obliterative Airway Disease (pages 2663–2674)

      V. Tiriveedhi, M. Takenaka, S. Ramachandran, A. E. Gelman, V. Subramanian, G. A. Patterson and T. Mohanakumar

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04191.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Selective ablation of FoxP3+ T regulatory cells exerts significant suppression of anti-MHC induced IL-8 mediated neutrophil infiltration and innate immune responses leading to Th17 mediated autoimmunity to lung associated self-antigens culminating in anti-MHC induced obliterative airway disease.

    5. You have free access to this content
      Induction of Alloimmune Tolerance in Heart Transplantation Through Gene Silencing of TLR Adaptors (pages 2675–2688)

      X. Zhang, M. Beduhn, X. Zheng, D. Lian, D. Chen, R. Li, L. K. S. Siu, A. Marleau, P. W. French, T. E. Ichim and W.-P. Min

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04196.x

      • image
      • image
      • image
      • image
      • image
      • image

      The authors highlight the therapeutic potential of siRNA in specifically knocking down the TLR adaptors MyD88 and TRIF and preventing heart graft rejection.

    6. You have free access to this content
      Fibronectin-α4β1 Interactions in Hepatic Cold Ischemia and Reperfusion Injury: Regulation of MMP-9 and MT1-MMP via the p38 MAPK Pathway (pages 2689–2699)

      S. Duarte, X.-D. Shen, C. Fondevila, R. W. Busuttil and A. J. Coito

      Article first published online: 19 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04161.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      This study reveals new insights into the role of fibronectin in hepatic cold ischemia and reperfusion injury, and provides evidence that fibronectin induces the expression of both MMP-9 and MT1-MMP/MMP-14 through activation of the p38 MAPK kinase pathway in macrophages.

    7. Clinical Science

      You have free access to this content
      Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial (pages 2700–2709)

      S. Arora, I. Erikstad, T. Ueland, V. Sigurdardottir, B. Ekmehag, K. Jansson, H. Eiskjær, H. E. Bøtker, S.-A. Mortensen, K. Saunamaki, E. Gude, A. Ragnarsson, D. Solbu, P. Aukrust and L. Gullestad

      Article first published online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04234.x

      • image
      • image
      • image
      • image
      • image

      In this sub-study of the NOCTET trial the authors demonstrate that conversion to everolimus and reduced calcineurin inhibitor therapy in heart transplant recipients is associated with a significant increase in calcified and necrotic tissue determined by virtual histology, and by a parallel rise in inflammatory biomarkers. See editorial by Eisen on page 2571.

    8. You have free access to this content
      A Peripheral Blood Diagnostic Test for Acute Rejection in Renal Transplantation (pages 2710–2718)

      L. Li, P. Khatri, T. K. Sigdel, T. Tran, L. Ying, M. J. Vitalone, A. Chen, S. Hsieh, H. Dai, M. Zhang, M. Naesens, V. Zarkhin, P. Sansanwal, R. Chen, M. Mindrinos, W. Xiao, M. Benfield, R. B. Ettenger, V. Dharnidharka, R. Mathias, A. Portale, R. McDonald, W. Harmon, D. Kershaw, V. M. Vehaskari, E. Kamil, H. J. Baluarte, B. Warady, R. Davis, A. J. Butte, O. Salvatierra and M. M. Sarwal

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04253.x

      • image
      • image
      • image

      This study documents the development of a blood-based gene panel for the noninvasive diagnosis of biopsy-proven acute kidney allograft rejection, and in doing so provides the basis for a blood test for acute rejection. See editorial by Bromberg and Iklé on page 2573.

    9. You have free access to this content
      Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three-Year Follow-Up (pages 2719–2729)

      M. M. Sarwal, R. B. Ettenger, V. Dharnidharka, M. Benfield, R. Mathias, A. Portale, R. McDonald, W. Harmon, D. Kershaw, V. M. Vehaskari, E. Kamil, H. J. Baluarte, B. Warady, L. Tang, J. Liu, L. Li, M. Naesens, T. Sigdel, Janie Waskerwitz and O. Salvatierra

      Article first published online: 13 JUN 2012 | DOI: 10.1111/j.1600-6143.2012.04145.x

      • image
      • image

      The authors present the results of a prospective, randomized, multicenter trial of steroid-free versus steroid-based immunosuppression in pediatric kidney transplantation, demonstrating the safety and efficacy of complete steroid avoidance in low-risk pediatric patients from infancy to adulthood.

    10. You have free access to this content
      Subclinical Inflammation and Chronic Renal Allograft Injury in a Randomized Trial on Steroid Avoidance in Pediatric Kidney Transplantation (pages 2730–2743)

      M. Naesens, O. Salvatierra, M. Benfield, R. B. Ettenger, V. Dharnidharka, W. Harmon, R. Mathias, M. M. Sarwal and for the SNS01-NIH-CCTPT Multicenter Trial

      Article first published online: 13 JUN 2012 | DOI: 10.1111/j.1600-6143.2012.04144.x

      • image
      • image
      • image

      This serial, semi-quantitative histological analysis of protocol and indicated biopsies in a prospective, randomized, multicenter trial of steroid-free versus steroid-based immunosuppression in pediatric kidney transplantation shows no detrimental effect of steroid avoidance on chronic histological injury.

    11. You have free access to this content
      Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation (pages 2744–2753)

      L. Mjörnstedt, S. S. Sørensen, B. von zur Mühlen, B. Jespersen, J. M. Hansen, C. Bistrup, H. Andersson, B. Gustafsson, L.H. Undset, H. Fagertun, D. Solbu and H. Holdaas

      Article first published online: 19 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04162.x

      • image
      • image
      • image

      In a randomized, open-label, multicenter study, conversion from cyclosporine to everolimus at week 7 after kidney transplantation improves one-year renal function, but is also associated with a higher rate of rejections and withdrawals due to adverse events.

    12. You have free access to this content
      BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies (pages 2754–2762)

      A. Thibault-Espitia, Y. Foucher, R. Danger, T. Migone, A. Pallier, S. Castagnet, C. G.-Gueguen, A. Devys, A. C.-Gautier, M. Giral, J.-P. Soulillou and S. Brouard

      Article first published online: 6 AUG 2012 | DOI: 10.1111/j.1600-6143.2012.04194.x

      • image
      • image
      • image
      • image

      BAFF constitutes a risk factor for renal graft dysfunction and the development of donor-specific antibodies.

    13. You have free access to this content
      Monitoring of Immunoglobulin Levels Identifies Kidney Transplant Recipients at High Risk of Infection (pages 2763–2773)

      M. Fernández-Ruiz, F. López-Medrano, P. Varela-Peña, D. Lora-Pablos, A. García-Reyne, E. González, J. M. Morales, R. San Juan, C. Lumbreras, E. Paz-Artal, A. Andrés and J. M. Aguado

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04192.x

      • image

      The authors analyze the incidence and clinical impact of hypogammaglobulinemia in kidney transplant recipients, and conclude that the systematic monitoring of humoral immunity identifies patients at high risk of posttransplant infection, offering the opportunity for preemptive immunoglobulin replacement therapy.

    14. You have free access to this content
      Pulsatile Pump Decreases Risk of Delayed Graft Function in Kidneys Donated After Cardiac Death (pages 2774–2780)

      S. A. Lodhi, K. E. Lamb, I. Uddin and H. U. Meier-Kriesche

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04179.x

      • image
      • image
      • image

      This retrospective study suggests that pulsatile machine perfusion might decrease the risk for delayed graft function even in kidneys procured after cardiac death.

    15. You have free access to this content
      Long-Term Results of Biopsy-Guided Selection and Allocation of Kidneys From Older Donors in Older Recipients (pages 2781–2788)

      L. Fernández-Lorente, L. Riera, O. Bestard, M. Carrera, M. Gomà, N. Porta, J. Torras, E. Melilli, S. Gil-Vernet, J. M. Grinyó and J. M. Cruzado

      Article first published online: 15 JUN 2012 | DOI: 10.1111/j.1600-6143.2012.04153.x

      • image
      • image

      This study analyzes a biopsy-guided strategy for renal allograft allocation and suggests a selective allocation scheme for dual kidney transplantation.

    16. You have free access to this content
      The Eurotransplant Donor Risk Index in Liver Transplantation: ET-DRI (pages 2789–2796)

      A. E. Braat, J. J. Blok, H. Putter, R. Adam, A. K. Burroughs, A. O. Rahmel, R. J. Porte, X. Rogiers, J. Ringers and for the European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC)

      Article first published online: 23 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04195.x

      • image

      This article describes the Eurotransplant Donor Risk Index, a model based on donor and transplant parameters with high predictive value for outcome after orthotopic liver transplantation in the Eurotransplant region.

    17. You have free access to this content
      Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-Analysis (pages 2797–2814)

      M. Rodríguez-Perálvarez, G. Germani, T. Darius, J. Lerut, E. Tsochatzis and A. K. Burroughs

      Article first published online: 15 JUN 2012 | DOI: 10.1111/j.1600-6143.2012.04140.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Evaluation of trough concentrations of tacrolimus after liver transplantation indicate that lower concentrations than currently recommended are safe in terms of acute cellular rejection, while reducing rates of renal impairment.

    18. You have free access to this content
      Cholesterol Metabolism Altered and FGF21 Levels High After Pediatric Liver Transplantation Despite Normal Serum Lipids (pages 2815–2824)

      S. Kosola, H. Lampela, H. Gylling, H. Jalanko, M. J. Nissinen, J. Lauronen, H. Mäkisalo, K. Vaaralahti, T. A. Miettinen, T. Raivio and M. P. Pakarinen

      Article first published online: 15 JUN 2012 | DOI: 10.1111/j.1600-6143.2012.04147.x

      • image
      • image
      • image
      • image

      Changes in cholesterol metabolism and increased serum levels of fibroblast growth factor 21 in long-term survivors of pediatric liver transplantation may predispose to increased cardiovascular disease risk later in life.

  9. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have full text access to this OnlineOpen article
      A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients (pages 2825–2831)

      R. R. Alloway, B. Sadaka, J. Trofe-Clark, A. Wiland and R. D. Bloom

      Article first published online: 3 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04174.x

      • image
      • image
      • image
      • image

      A randomized pharmacokinetic study of generic versus reference tacrolimus in kidney transplant recipients indicates that the generic has a similar pharmacokinetic profile to the reference drug and is bioequivalent in kidney transplant recipients according to U.S. Food and Drug Administration and European Medicines Agency guidelines.

    2. You have free access to this content
      Liver Transplantation Using Chagas-Infected Donors in Uninfected Recipients: A Single-Center Experience Without Prophylactic Therapy (pages 2832–2837)

      L. McCormack, E. Quiñónez, N. Goldaracena, M. Anders, V. Rodríguez, F. Orozco Ganem and R. C. Mastai

      Article first published online: 19 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04160.x

      Liver grafts from Chagas-infected donors can be safely used for transplanting uninfected recipients without the need of prophylactic therapy but under strict scheduled parasitological infection screening.

  10. Case Reports

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      Successful Emergent Lung Transplantation After Remote Ex Vivo Perfusion Optimization and Transportation of Donor Lungs (pages 2838–2844)

      C. H. Wigfield, M. Cypel, J. Yeung, T. Waddell, C. Alex, C. Johnson, S. Keshavjee and R. B. Love

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04175.x

      • image
      • image
      • image

      This case report details the first lung transplantation facilitated through the application of remote ex vivo lung perfusion.

    2. You have free access to this content
      Preformed Donor HLA-DP-Specific Antibodies Mediate Acute and Chronic Antibody-Mediated Rejection Following Renal Transplantation (pages 2845–2848)

      E. C. Jolly, T. Key, H. Rasheed, H. Morgan, A. Butler, N. Pritchard, C. J. Taylor and M. R. Clatworthy

      Article first published online: 3 JUL 2012 | DOI: 10.1111/j.1600-6143.2012.04172.x

      • image
      • image

      The authors present two case reports in which isolated donor-specific HLA-DP antibodies were associated with recurrent antibody-mediated rejection and allograft loss following renal transplantation.

  11. Reports From the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
      West Nile Virus Disease and Other Arboviral Diseases—United States, 2011 (pages 2849–2854)

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04298.x

      • image

      This article highlights the 2011 epidemiology of West Nile virus and other arboviruses, a significant cause of morbidity in transplant recipients.

  12. Images in Transplantation

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. CME

      You have free access to this content
      Biliary Leak With Tardus Parvus Arterial Waveform After Liver Transplantation (pages 2855–2857)

      G. R. Veillette, D. S. Bedi and S. Feng

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04222.x

      • image
      • image
  13. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Comprehensive Review
    6. Minireviews
    7. Meeting Report
    8. Personal Viewpoint
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports From the CDC: MMWR
    13. Images in Transplantation
    14. Letters to the Editor
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content

SEARCH

SEARCH BY CITATION